BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Valentis

Valentis is a biotechnology company that was engaged in the development of innovative products for peripheral arterial disease (PAD), a large and unsatisfied market. On July 11, 2006 Valentis announced that no statistically significant difference was seen in the primary endpoint or any of the secondary endpoints in its Phase IIb clinical trial of VLTS 934 in PAD. The primary efficacy endpoint in the study was improvement in exercise tolerance on an escalating grade treadmill after 90 days in patients receiving VLTS 934 versus patients receiving placebo. While Valentis focused its efforts on the development of novel peripheral arterial disease therapeutics, its technologies are being applied by its collaborators for the development of therapeutics to treat a variety of indications including infectious diseases and cancer.


Contact Details:
533 Airport Blvd Ste. 400
Burlingame
CA
94010
United States of America
Tel:650 697 1900
Fax:650-652-1990
Email:ir@valentis.com
WWW:

www.valentis.com/




Loading...

Recent Publications by Valentis:

The antiprogestin-dependent GeneSwitch system for regulated gene therapy.
Antiprogestin-controlled gene regulation systems, initially developed by...
18th August, 2004
Valentis, Inc., 863A Mitten Road, Burlingame, CA 94010, USA. Steroids. 2003 Nov;68(10-13):1085-94.
Regulated production of proteins from muscle using gene transfer: potential therapeutic applications.
The ability to produce high-level transgene expression following the...
14th July, 2004
Valentis, Inc, Burlingame, CA 94010, USA. Expert Opin Biol Ther. 2003 Apr;3(2):277-91.
DOI Direct Link
Biodistribution and safety studies of hDel-1 plasmid-based gene therapy in mouse and rabbit models.
A plasmid encoding the human developmentally regulated endothelial locus-1...
24th June, 2004
Valentis, J Pharm Pharmacol. 2004 Feb;56(2):177-85.
DOI Direct Link
Plasmid-based gene transfer and antiprogestin-controllable transgene expression.
Inhibition of the neovascularization of tumors has proven efficacious in...
30th January, 2004
Valentis, Inc., 8301 New Trails Drive, The Woodlands, TX 77381, USA. Ernst Schering Res Found Workshop. 2003;(43):225-44.
Antiprogestin-controllable transgene regulation in vivo.
Gene control systems that provide temporal and spatial regulation of...
13th March, 2003
Valentis, Curr Opin Biotechnol. 2002 Oct;13(5):453-8.

View more Valentis research publications.

BioNews Results for Valentis:

'Lithuania Pharmaceuticals and Healthcare Report Q2 2008' Reveals Forecasts for the Coming Five Years Annual G
Houston Chronicle:  Jul 14 2008 6:34PM Matching: valentis
'Lithuania Pharmaceuticals and Healthcare Report Q2 2008' Reveals Forecasts for the Coming Five Years Annual G
Earthtimes.org:  Jul 14 2008 5:47PM Matching: valentis
'Lithuania Pharmaceuticals and Healthcare Report Q2 2008' Reveals Forecasts for the Coming Five Years Annual G
Yahoo! Canada:  Jul 14 2008 5:43PM Matching: valentis

Valentis Patents:

US Patent No.Title
7314746 Apparatus and method for preparative scale purification of nucleic acids
6235310 Methods of delivery using cationic lipids and helper lipids
6271206 Sonic nebulized nucleic acid/cationic liposome complexes and methods for pulmonary gene delivery
6271209 Cationic lipid formulation delivering nucleic acid to peritoneal tumors
6303378 Methods for preparing polynucleotide transfection complexes

View more Valentis patents.

Valentis (VLTS) Financial information Links from Barchart

VLTS Quote from from Barchart.com
VLTS Chart from from Barchart.com
VLTS Profile from from Barchart.com
VLTS Opinion from from Barchart.com

View more Valentis finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 346 times since April 2007, the link to the organisation's website has been followed 74 times

Recent Search Terms used to find this page: valentis | valentis | Valentis Inc. The Woodlands Texas | Valentis The Woodlands TX | valentis woodlands | valentis | valentis burlingame | Valentis VLTS | VALENTIS woodlands | valentis | .

Search for more companies in Burlingame

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Valentis
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.